Prognosis of CRT-treated and CRT-untreated unselected population with LBBB in Stockholm County
Europace · 2023
DOI: 10.1093/europace/euad192 ↗Kurz gefasst
Kommentar in der Zeitschrift Europace, 2023. Verfasst von Paolo Gatti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Karolinska Institutet, Norrbacka S1:02, Eugeniavägen 27-31, 171 76 Stockholm, Sweden. Hauptthemen laut MEDLINE: Cardiac Resynchronization Therapy, Heart Failure, Defibrillators, Implantable. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medtronic.
Abstract (Originalsprache)
Aims
Left bundle branch block (LBBB) might be the first finding of cardiovascular diseases but also the prerequisite for cardiac resynchronization therapy (CRT) in heart failure (HF) with reduced ejection fraction (HFrEF). The prognosis for patients with LBBB and the implications of CRT in an unselected real-world setting are the focus of our study. Methods and results A central electrocardiogram (ECG) database and national registers have been screened to identify patients with LBBB. Predictors of HF and the use of CRT were identified with Cox models. The hazard ratios (HRs) of death, cardiovascular death (CVD), and HF hospitalization (HFH) were estimated according to CRT use. Of 5359 patients with LBBB and QRS > 150 ms, median age 76 years, 36% were female. At the time of index ECG, 41% had a previous history of HF and 27% developed HF. Among 1053 patients with a class I indication for CRT, only 60% received CRT with a median delay of 137 days, and it was associated with a lower risk of death [HR: 0.45, 95% confidence interval (CI): 0.36–0.57], CVD (HR: 0.47, 95% CI: 0.35–0.63), and HFH (HR: 0.56, 95% CI: 0.48–0.66). The age of over 75 years and the diagnosis of dementia and chronic obstructive pulmonary disease were predictors of CRT non-use, while having a pacing/defibrillator device independently predicted CRT use.
Conclusion
In an unselected LBBB population, CRT is underused but of great value for HF patients. Therefore, it is crucial to find ways of better implementing and understanding CRT utilization and characteristics that influence the management of our patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Department of Medicine, Karolinska Institutet, Norrbacka S1:02, Eugeniavägen 27-31, 171 76 Stockholm, Sweden.
- Department of Cardiology, Karolinska Universitetssjukhuset, Stockholm, Sweden.
- Division of Cardiology, Department of Medical Sciences, University of Turin, Azienda Ospedaliero Universitaria (A.O.U.) Città della Salute e della Scienza di Torino, 10126 Turin, Italy.
ORCID-Profile: Paolo Gatti, Stefan Lind, Ingibjörg Kristjánsdóttir, Gianluigi Savarese, Matteo Anselmino, Cecilia Linde, Fredrik Gadler
Förderung
- Medtronic
Zitieren
APA
Gatti, P., Lind, S., Kristjánsdóttir, I., Azari, A., Savarese, G., Anselmino, M., Linde, C., & Gadler, F. (2023). Prognosis of CRT-treated and CRT-untreated unselected population with LBBB in Stockholm County. Europace. https://doi.org/10.1093/europace/euad192
Vancouver
Gatti P, Lind S, Kristjánsdóttir I, Azari A, Savarese G, Anselmino M, et al. Prognosis of CRT-treated and CRT-untreated unselected population with LBBB in Stockholm County. Europace. 2023. doi:10.1093/europace/euad192
BibTeX
@article{Gatti2023,
author = {Gatti, Paolo and Lind, Stefan and Kristjánsdóttir, Ingibjörg and Azari, Ava and Savarese, Gianluigi and Anselmino, Matteo and Linde, Cecilia and Gadler, Fredrik},
title = {Prognosis of CRT-treated and CRT-untreated unselected population with LBBB in Stockholm County},
journal = {Europace},
year = {2023},
doi = {10.1093/europace/euad192}
}
EUVIMED